Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $28.71 $35.40 Friday, 10th May 2024 AGIO stock ended at $33.00. This is 0.243% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 1.97% from a day low at $32.45 to a day high of $33.09.
90 days $24.69 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Nov 28, 2016 $63.09 $63.93 $60.58 $60.90 357 395
Nov 25, 2016 $63.86 $64.52 $62.07 $63.67 213 162
Nov 23, 2016 $60.78 $64.17 $59.69 $63.83 514 141
Nov 22, 2016 $64.95 $65.45 $61.44 $61.86 469 129
Nov 21, 2016 $62.67 $65.18 $62.00 $64.52 520 990
Nov 18, 2016 $62.72 $63.55 $62.07 $62.54 387 746
Nov 17, 2016 $62.37 $63.24 $61.55 $62.81 506 806
Nov 16, 2016 $66.64 $67.50 $61.87 $61.94 776 079
Nov 15, 2016 $66.35 $67.74 $64.54 $67.25 556 083
Nov 14, 2016 $64.98 $67.43 $63.01 $66.98 882 140
Nov 11, 2016 $62.50 $64.66 $61.22 $64.22 868 111
Nov 10, 2016 $60.00 $64.50 $59.74 $63.77 1 219 253
Nov 09, 2016 $56.56 $60.00 $55.68 $59.50 1 216 076
Nov 08, 2016 $54.03 $54.03 $54.03 $54.03 616 404
Nov 07, 2016 $52.29 $52.29 $52.29 $52.29 636 600
Nov 04, 2016 $49.46 $49.46 $49.46 $49.46 854 800
Nov 03, 2016 $47.63 $47.63 $47.63 $47.63 1 089 600
Nov 02, 2016 $46.10 $46.10 $46.10 $46.10 1 187 300
Nov 01, 2016 $48.29 $48.29 $48.29 $48.29 571 800
Oct 31, 2016 $47.84 $47.84 $47.84 $47.84 287 800
Oct 28, 2016 $48.58 $48.58 $48.58 $48.58 574 100
Oct 27, 2016 $48.30 $48.30 $48.30 $48.30 450 200
Oct 26, 2016 $48.72 $48.72 $48.72 $48.72 473 700
Oct 25, 2016 $48.72 $48.72 $48.72 $48.72 315 500
Oct 24, 2016 $49.01 $49.01 $49.01 $49.01 377 500
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT